NCT04862117View on ClinicalTrials.gov

Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 28, 2018

Primary Completion Date

December 8, 2026

Study Completion Date

December 8, 2026

Conditions

Rheumatoid Arthritis

Interventions

DEVICE

SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System

Active Implantable Vagus Nerve Stimulation device.

Trial Locations (4)

11021

Northwell Health, Great Neck

16635

Altoona Center for Clinical Research, Duncansville

33180

Arthritis & Rheumatic Disease Specialties, Aventura

33542

Florida Medical Clinic, PA, Zephyrhills

All Listed Sponsors

lead

SetPoint Medical Corporation

INDUSTRY

NCT04862117 - Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA) | Biotech Hunter | Biotech Hunter